AST SpaceMobile closes its most dissonant week of 2026 with the stock up 22%, short interest at an all-time high, the borrow market at its tightest-ever reading, and the CEO having sold $146 million of stock into the bounce.
The positioning picture is now genuinely extreme. Short interest reached 25.4% of the free float on June 30 — the highest ORTEX has recorded for this name — up from 18.3% on June 8. That is eight percentage points of float absorbed in three weeks, with shorts adding 2.6% in a single session on June 30 alone. More striking is what has happened to borrow availability. It has collapsed to just 6.77% — the tightest reading in the stock's 52-week history and a new floor. A week ago it was 19%. A fortnight ago, 43%. Roughly 14 shares are already out on loan for every one still available to borrow. The cost to borrow has climbed 15% on the week to just over 1%, still modest in absolute terms but accelerating from a base near 0.66% in early June. The ORTEX short score has ground higher to 70.6, its highest reading of the year, ranking in the 2nd percentile of all stocks — meaning virtually every other name in the universe carries less short pressure. Yet the options market is not alarmed: the put/call ratio at 0.45 is barely above its 20-day average of 0.44, and well inside the 52-week range. Call activity still dominates, suggesting the options crowd is not bracing for a collapse.
The insider story deserves its own paragraph — because it runs directly counter to the bullish options tone. On June 22, founder and CEO Abel Avellan sold 2.5 million shares at $58.68, raising $146.7 million. That sale came with the stock trading well below its current level, which makes it more notable rather than less: he locked in proceeds near a recent cycle low. Since late May, every named C-suite officer has sold. The CFO, CTO, President, and COO all cleared stock at prices between $93 and $126 — materially above where the stock closed on June 30 at $88.86. Net insider activity over the past 90 days amounts to sales of roughly $449 million worth of stock. The top institutional holder remains Alphabet with a 2.99% stake, unchanged as of March 31.
The Street has cooled considerably. Deutsche Bank downgraded to Hold from Buy in late May, cutting its target to $106 from $117. UBS trimmed its Neutral target to $80. With the mean analyst target at around $81 — below the current price of $88.86 — the consensus implies modest downside at this level. Barclays maintains an Underweight with a $65 target. The analyst data is dated as of early June, so some of these targets pre-date the current price level; treat the implied returns with appropriate caution. The bull case centres on ASTS's direct-to-device IP, MNO partnerships, and a 5G constellation that no rival has yet matched at scale. The bear case is blunt: capital-intensive, loss-making, dependent on third-party launchers, and competing against SpaceX, which already operates at a cost and cadence ASTS cannot match. Price-to-book has compressed about 23% over the past month to around 14.7x, tracking the stock's -22% one-month decline even as this week's bounce partially offset that move.
Among peers, IRDM gained 24% on the week — outpacing even ASTS — while TSAT added 16%. The satellite carrier space broadly caught a bid. That peer momentum reinforces the view that some of this week's ASTS move was sector-driven rather than company-specific. Prior earnings prints offer a sobering datapoint: the June 12 Q1 release sent the stock down 10% the day after and 25% over the following five sessions. The May 11 print also fell 2.8% on the day, though it recovered 16% over the following week.
The next earnings event is August 11. Between now and then, the dominant question is whether borrow availability — already at a 52-week low — tightens further and starts translating into a cost-to-borrow spike, or whether the stock's inability to hold above $90 invites fresh short supply back into the lending pool before then.
See the live data behind this article on ORTEX.
Open ASTS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.